Please login to the form below

Not currently logged in
Email:
Password:

belimumab

This page shows the latest belimumab news and features for those working in and with pharma, biotech and healthcare.

Biogen scores mid-stage trial win for lupus drug BIIB059

Biogen scores mid-stage trial win for lupus drug BIIB059

It has very few treatment options – the last treatment to be approved by the FDA was GlaxoSmithKline’s  Benlysta (belimumab) back in 2011, which ended a 50-year drought in new

Latest news

More from news
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Building a business that is lean and specialised Building a business that is lean and specialised

    The company was Human Genome Sciences and its acquirer, GlaxoSmithKline, had its eye on gaining full control of Benlysta (belimumab), the lupus product that the two had been co-marketing.

  • Pharma deals during July 2012 Pharma deals during July 2012

    These are Benlysta (belimumab), an antibody approved for the treatment of lupus; darapladib, a phase III small molecule drug for the treatment of cardiovascular disease; and albiglutide, an albumin-fusion protein

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

Graphite is a digital agency which partners with globally respected healthcare organisations to create powerful digital experiences....

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics